查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585757

骨移植市场：按类型、应用和最终用户划分 - 全球预测 2025-2030

Bone Allografts Market by Type (Corticocancellous Bone Allografts, Massive Structural Bone Allografts, Osteoinductive Bone Allografts), Application (Dental, Reconstruction & Traumatology, Spine), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年骨移植市场估值为50亿美元，预计2024年将达54.1亿美元，复合年增长率为8.63%，预计2030年将达到89.4亿美元。

骨移植涉及将骨组织从供体移植到受体。这种生物材料在整形外科手术中非常重要，可提供结构支撑并促进自然骨骼生长。骨移植的需求涉及范围广泛，包括骨折、脊椎融合手术、重组手术和牙科手术，在这些情况下，由于供体部位发病率或可用性有限等因素，自体移植可能不可行。最终用途主要是在医院、整形外科诊所和牙科诊所。骨移植市场的关键成长要素包括全球人口老化、骨质疏鬆症和关节炎盛行率上升以及对微创整形外科手术的需求不断增加。此外，技术进步和生物相容性的提高提高了骨移植的有效性，促进了其更广泛的采用。然而，疾病传播风险、可能的免疫反应排斥以及严格的监管核准等挑战正在阻碍市场成长。医疗基础设施不断扩大的新兴市场以及脱矿骨基质和莫氏鬆质骨移植物等创新加工技术的开拓，以增强移植物的整合和性能，都存在机会。该调查将重点放在模仿同种异体移植物特性的合成替代品的研究，并探索与组织库的合作伙伴关係，以简化骨移植物的采购和加工。增强移植物功能的生物工程技术，例如整合生长因子和干细胞，是重要的创新领域。儘管存在合成替代品和自体移植的竞争，但由于组织工程的进步以及安全性和有效性标准提高所带来的广泛接受，该市场本质上具有弹性，并且具有成长潜力。因此，企业应注重技术创新和策略联盟，以保持竞争力并有效应对不断增长的需求。

主要市场统计
基准年[2023] 50亿美元
预测年份 [2024] 54.1亿美元
预测年份 [2030] 89.4亿美元
复合年增长率（%） 8.63%

市场动态：快速发展的骨移植市场的关键市场洞察

供需的动态交互作用正在改变骨移植市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 骨质疏鬆症和牙科疾病的盛行率增加
    • 整形外科手术数量增加
    • 肌肉骨骼疾病 (MSD) 增加
  • 市场限制因素
    • 围绕骨移植治疗费用高的担忧
  • 市场机会
    • 生物相容性合成骨移植简介
    • 医疗设备领域新技术进展
  • 市场挑战
    • 骨移植手术相关的併发症和伦理问题

波特五力：驾驭骨移植市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解骨移植市场的外部影响

外部宏观环境因素在塑造骨移植市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解骨移植市场的竞争格局

对骨移植市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位基质骨移植市场供应商绩效评估

FPNV定位矩阵是评估骨移植市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了骨移植市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，骨移植市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 骨质疏鬆症和牙科疾病增加
      • 整形外科手术增加
      • 肌肉骨骼疾病 (MSD) 病例增加
    • 抑制因素
      • 对昂贵的骨移植治疗的担忧
    • 机会
      • 生物相容性合成骨移植简介
      • 医疗设备领域新技术进展
    • 任务
      • 骨移植手术相关的併发症和伦理问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章骨移植市场：依类型

  • 皮质海绵状肝血管瘤植骨
  • 大型结构性骨移植
  • 骨诱导骨移植

第七章骨移植市场：依应用分类

  • 牙科
  • 重组与创伤学
  • 脊椎
  • 运动外科

第八章骨移植市场：依最终用户分类

  • 门诊手术中心
  • 医院和专科诊所

第九章美洲骨移植市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太骨移植市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲的骨移植市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AlloSource
  • Baxter International Inc.
  • Biomatlante
  • Biowy Corporation
  • botiss biomaterials GmbH
  • Geistlich Pharma AG
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Lynch Biologics, LLC
  • Medical Device Business Services, Inc.
  • Medtronic PLC
  • Nobel Biocare Services AG
  • NuVasive, Inc.
  • Orthofix US LLC
  • PuraGraft
  • Smith & Nephew PLC
  • Stryker Corporation
  • Surgical Esthetics Biomedical
  • SURGILOGIX
  • TBF Tissue Engineering
  • Wright Medical Group NV
  • Xtant Medical
  • Zimmer Biomet
Product Code: MRR-F927BA462598

The Bone Allografts Market was valued at USD 5.00 billion in 2023, expected to reach USD 5.41 billion in 2024, and is projected to grow at a CAGR of 8.63%, to USD 8.94 billion by 2030.

Bone allografts involve transplanting bone tissue from a donor to a recipient, typically to repair or replace bone following injury or disease. This biological material is critical in orthopedic surgeries, providing structural support and promoting natural bone growth. The necessity of bone allografts is underscored by their role in addressing a wide array of conditions including fractures, spinal fusions, reconstructive surgeries, and dental procedures, where autografts may not be viable due to factors such as donor site morbidity or limited availability. The end-use scope revolves around hospitals, orthopedic clinics, and dental practices. Key growth factors for the bone allograft market include an aging global population, rising incidence of osteoporosis and arthritis, and increased demand for minimally invasive orthopedic procedures. Furthermore, technological advancements and improved biocompatibility in allograft processing enhance their efficacy, encouraging wider adoption. However, challenges such as the risk of disease transmission, potential for immune response rejection, and stringent regulatory approvals hamper market growth. Opportunities lie in emerging markets where healthcare infrastructure is expanding, as well as in the development of innovative processing techniques such as demineralized bone matrix and morselized cancellous allografts to enhance graft integration and performance. Recommendations would focus on investing in research for synthetic alternatives that mimic allograft properties and exploring partnerships with tissue banks to streamline the procurement and processing of bone allografts. An area for significant innovation is bioengineering techniques that enhance graft functionality, such as incorporating growth factors or stem cells. The market is inherently resilient, although competitive with synthetic alternatives and autografts, offering potential for growth driven by advancements in tissue engineering and a broader acceptance stemming from improved safety and efficacy standards. Consequently, businesses should focus on innovation and strategic collaborations to maintain competitiveness and meet rising demand effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 5.00 billion
Estimated Year [2024] USD 5.41 billion
Forecast Year [2030] USD 8.94 billion
CAGR (%) 8.63%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bone Allografts Market

The Bone Allografts Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of osteoporosis and dental problems
    • Rising number of orthopedic surgeries
    • Increase in cases of Musculoskeletal disorders (MSD)
  • Market Restraints
    • Concern associated with expensive treatments of bone allografts
  • Market Opportunities
    • Introduction of biocompatible synthetic bone allografts
    • Emerging technological advancement in medical device sector
  • Market Challenges
    • Associated complications and ethical issues of bone grafting surgeries

Porter's Five Forces: A Strategic Tool for Navigating the Bone Allografts Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bone Allografts Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bone Allografts Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bone Allografts Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bone Allografts Market

A detailed market share analysis in the Bone Allografts Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bone Allografts Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bone Allografts Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bone Allografts Market

A strategic analysis of the Bone Allografts Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bone Allografts Market, highlighting leading vendors and their innovative profiles. These include AlloSource, Baxter International Inc., Biomatlante, Biowy Corporation, botiss biomaterials GmbH, Geistlich Pharma AG, Integra LifeSciences Holdings Corporation, Johnson & Johnson Services, Inc., Lynch Biologics, LLC, Medical Device Business Services, Inc., Medtronic PLC, Nobel Biocare Services AG, NuVasive, Inc., Orthofix US LLC, PuraGraft, Smith & Nephew PLC, Stryker Corporation, Surgical Esthetics Biomedical, SURGILOGIX, TBF Tissue Engineering, Wright Medical Group N.V., Xtant Medical, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Bone Allografts Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Corticocancellous Bone Allografts, Massive Structural Bone Allografts, and Osteoinductive Bone Allografts.
  • Based on Application, market is studied across Dental, Reconstruction & Traumatology, Spine, and Sports Surgery.
  • Based on End-User, market is studied across Ambulatory Surgical Centers and Hospital & Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of osteoporosis and dental problems
      • 5.1.1.2. Rising number of orthopedic surgeries
      • 5.1.1.3. Increase in cases of Musculoskeletal disorders (MSD)
    • 5.1.2. Restraints
      • 5.1.2.1. Concern associated with expensive treatments of bone allografts
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of biocompatible synthetic bone allografts
      • 5.1.3.2. Emerging technological advancement in medical device sector
    • 5.1.4. Challenges
      • 5.1.4.1. Associated complications and ethical issues of bone grafting surgeries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bone Allografts Market, by Type

  • 6.1. Introduction
  • 6.2. Corticocancellous Bone Allografts
  • 6.3. Massive Structural Bone Allografts
  • 6.4. Osteoinductive Bone Allografts

7. Bone Allografts Market, by Application

  • 7.1. Introduction
  • 7.2. Dental
  • 7.3. Reconstruction & Traumatology
  • 7.4. Spine
  • 7.5. Sports Surgery

8. Bone Allografts Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospital & Specialty Clinics

9. Americas Bone Allografts Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bone Allografts Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bone Allografts Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AlloSource
  • 2. Baxter International Inc.
  • 3. Biomatlante
  • 4. Biowy Corporation
  • 5. botiss biomaterials GmbH
  • 6. Geistlich Pharma AG
  • 7. Integra LifeSciences Holdings Corporation
  • 8. Johnson & Johnson Services, Inc.
  • 9. Lynch Biologics, LLC
  • 10. Medical Device Business Services, Inc.
  • 11. Medtronic PLC
  • 12. Nobel Biocare Services AG
  • 13. NuVasive, Inc.
  • 14. Orthofix US LLC
  • 15. PuraGraft
  • 16. Smith & Nephew PLC
  • 17. Stryker Corporation
  • 18. Surgical Esthetics Biomedical
  • 19. SURGILOGIX
  • 20. TBF Tissue Engineering
  • 21. Wright Medical Group N.V.
  • 22. Xtant Medical
  • 23. Zimmer Biomet

LIST OF FIGURES

  • FIGURE 1. BONE ALLOGRAFTS MARKET RESEARCH PROCESS
  • FIGURE 2. BONE ALLOGRAFTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BONE ALLOGRAFTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BONE ALLOGRAFTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BONE ALLOGRAFTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BONE ALLOGRAFTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BONE ALLOGRAFTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BONE ALLOGRAFTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BONE ALLOGRAFTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BONE ALLOGRAFTS MARKET DYNAMICS
  • TABLE 7. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY CORTICOCANCELLOUS BONE ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY MASSIVE STRUCTURAL BONE ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY OSTEOINDUCTIVE BONE ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY DENTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY RECONSTRUCTION & TRAUMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY SPINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY SPORTS SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY HOSPITAL & SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES BONE ALLOGRAFTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. BONE ALLOGRAFTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. BONE ALLOGRAFTS MARKET, FPNV POSITIONING MATRIX, 2023